Related Experiment Video
Updated: Jun 11, 2026

Production of Near-Infrared Sensitive, Core-Shell Vaccine Delivery Platform
Published on: October 20, 2020
Vaccine Manufacturing--Second Annual visiongain Conference
1Protein Sciences Corp, 1000 Research Parkway, Meriden, CT 06450, USA. cmcpherson@proteinsciences.com
Abstract:
The Vaccine Manufacturing--Second Annual visiongain Conference, held in London, included topics covering new technological developments in the field of influenza vaccine research. This conference report highlights selected presentations on influenza vaccine development in mammalian, insect and avian embryonic cells, regulatory considerations for cell culture-based influenza vaccine production, an improved animal model for influenza infection, and considerations for designing vaccine manufacturing facilities. Investigational drugs discussed include FluBiovax (Immunobiology Ltd) and FluBlok (Protein Sciences Corp/UMN Pharma Inc).
Related Concept Videos
Vaccine Production
Vaccines
Production of Pharmaceuticals
Vaccinations
Ophthalmic Drug Delivery Systems
Vision
